First-in-human pharmacokinetics of tamoxifen and its metabolites in the milk of a lactating mother: a case study.

Breast cancer represents the most frequent neoplasm diagnosed in women of childbearing age. When the tumour is oestrogen receptor-positive, tamoxifen is among the recommended endocrine treatments. Lactating women are advised not to breastfeed while receiving tamoxifen.

Plasma pentraxin-3 as a marker of bioincompatibility in hemodialysis patients.

Introduction: Hemodialysis (HD)-induced inflammation has a pathogenetic role in patients with end-stage renal disease (ESRD). The aim of the present study was to assess whether pentraxin-3 (PTX3) could be a reliable biomarker of HD-induced inflammation and of membrane biocompatibility.

Methods: We prospectively enrolled 31 HD patients.